Table 1 Haematological and biochemical profile of the patient at disease onset and during the 10-year-long follow-up
Parameter | Dec 2009 | Feb 2010 | June 2010 | Jan 2012 | Jan 2013 | Jan 2015 | Jan 2017 | Jan 2019 |
|---|---|---|---|---|---|---|---|---|
Body weight (kg) | 78 | 58 | 63 | 67 | 78 | 73 | 71 | 70 |
Hemoglobin (g/dl) | 8.9 | 10.4 | 11.8 | 11.2 | 12.1 | 12.0 | 12.2 | 11.9 |
Serum urea (mg/dl) | 78 | 91 | 150 | 176 | 168 | 128 | 145 | 133 |
Serum creatinine (mg/dl) | 8.8 | 9.4 | 10.7 | 11.3 | 11.2 | 11.8 | 12.0 | 12.5 |
Serum albumin (g/dl) | 2.4 | 3.3 | 3.8 | 3.7 | 4.1 | 4.0 | 4.2 | 4.1 |
Serum calcium (mg/dl) | 7.5 | 8.3 | 8.9 | 8.4 | 8.7 | 9.0 | 9.3 | 9.2 |
Serum phosphate (mg/dl) | 2.6 | 3.5 | 4.5 | 6.5 | 5.5 | 4.9 | 5.8 | 5.5 |
PTH (pmol/l) | 22.9 | 24.9 | 29.4 | 49.5 | 51.0 | 54.2 | 43.0 | 29.6 |
C-reactive-protein (mg/dl) | 10.8 | 7.1 | 2.1 | 1.3 | 1.23 | 1.1 | 1.0 | 1.3 |
Treatment for the secondary hyperparathyroidism | ||||||||
Calcium carbonate | – | – | – | 1500 mg/d | 1500 mg/d | 1500 mg/d | 1500 mg/d | 3000 mg/d |
Paricalcitol | – | – | 2.5 μgr/HD | 7.5 μgr/HD | 5.0 μgr/HD | 5.0 μgr/HD | 5.0 μgr/HD | 7.5 μgr/HD |